Teriparatide or alendronate in glucocorticoid-induced osteoporosis
Saag, Kenneth G × Shane, Elizabeth Boonen, Steven Marin, Fernando Donley, David W Taylor, Kathleen A Dalsky, Gail P Marcus, Robert #
Massachusetts medical soc
New england journal of medicine vol:357 issue:20 pages:2028-2039
Background: Bisphosphonate therapy is the current standard of care for the prevention and treatment of glucocorticoid-induced osteoporosis. Studies of anabolic therapy in patients who are receiving long-term glucocorticoids and are at high risk for fracture are lacking.